Grifols Stock

Grifols Financial Leverage

The Financial Leverage (Equity Multiplier) of Grifols (GRF.MC) as of Aug 20, 2026 is 3.74. In the previous year, Financial Leverage (Equity Multiplier) was 3.64 — a change of 2.78% (higher).

Financial Leverage

3.74

YoY

2.78%

Last updated:

Financial Leverage (Equity Multiplier) of Grifols is 2026 3.74 . Financial Leverage (Equity Multiplier) of Grifols was 2025 3.64 . It decreases by 2.78% higher compared to the previous year.
Access this data via the Eulerpool API

Grifols Stock analysis

What does Grifols do? Grifols SA is a globally operating company specialized in the manufacture and marketing of medical products and technologies. The company is headquartered in Barcelona, Spain and has been in existence for over 75 years. Grifols focuses on improving the quality of life through the production and marketing of blood products and services, diagnostics, and hospital pharmaceuticals. It has four main business areas: Bioscience, Hospital, Diagnostic, and Bio Supplies. Grifols emphasizes research and development to meet customer needs. It has introduced various products, including AlfaBIO, Vistogard, ID Core XT, NEO Blood Bank, and MIRASOL Pathogen Reduction Technology. Grifols is committed to innovation and quality, providing products and services that cater to a wide range of customers. Additionally, it is a significant employer in the biotechnology industry and contributes to economic development in different regions. Grifols is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Grifols stock

Financial Leverage (Equity Multiplier) of Grifols is 3.74 in 2026.

Financial Leverage (Equity Multiplier) of Grifols changed from 3.64 to 3.74, representing a 2.78% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Grifols since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Grifols with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Grifols

All Key Metrics — Grifols